JPMorgan Chase & Co. is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Coverage clusters in markets, which accounts for 3 of those 4, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Telsey Advisory Group
JPMorgan Chase & Co. is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Coverage clusters in markets, which accounts for 3 of those 4, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. Their average consequence score of 5 runs below the beat's 6 for that window. Across a 104-day span, the pace is roughly 0.3 stories per week. We currently track 4 Finance stories that mention Telsey Advisory Group, published between June 14, 2026 and September 25, 2026.
Stories tracked
4
Per week
0.3
Sources per story
2
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 1832 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Telsey Advisory Group. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen upgraded CVS Health to strong-buy, adding to 22 buy ratings and a $107.24 consensus target that implies 23% upside from Friday's $87.02 open. Macy's and NewJersey Resources were also upgraded, signaling broad analyst optimism.
New Financial Health Network and USC data show more than a quarter of student loan borrowers are financially vulnerable as inflation and safety-net cuts squeeze lower-income households. Consumer spending is holding up for now, but analysts warn elevated inflation and oil prices could pressure 2026 sales and credit quality.
Mitsubishi UFJ's Q2 13F shows a 22.3% reduction in Nike and 6.4% in Zoetis, just as sell-side targets on NKE cluster at $42–$47. For finance professionals, the filings highlight institutional rebalancing, ownership concentration, and analyst caution as key sentiment signals.
Amazon’s 1.5% gain to $241.51 comes with 57 Buy ratings and a consensus price target of $312.78. Are the growth catalysts enough to justify the valuation?